Phibro Animal Health (NASDAQ:PAHC) Upgraded at BNP Paribas

BNP Paribas upgraded shares of Phibro Animal Health (NASDAQ:PAHC) to a hold rating in a report issued on Monday morning,Zacks.com reports.

Several other equities research analysts have also recently weighed in on the stock. Morgan Stanley raised their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Thursday, May 8th. BNP Paribas Exane raised shares of Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price objective on the stock in a research note on Monday. Finally, Wall Street Zen raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and an average price target of $20.80.

Phibro Animal Health Trading Down 2.0%

Shares of PAHC stock opened at $23.96 on Monday. Phibro Animal Health has a 52-week low of $16.16 and a 52-week high of $26.55. The stock has a market cap of $971.10 million, a price-to-earnings ratio of 30.72, a P/E/G ratio of 0.46 and a beta of 0.74. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91. The firm has a fifty day moving average of $21.49 and a 200-day moving average of $21.91.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.11. The business had revenue of $347.80 million during the quarter, compared to analysts’ expectations of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. On average, equities research analysts forecast that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.00%. Phibro Animal Health’s payout ratio is 61.54%.

Hedge Funds Weigh In On Phibro Animal Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Sterling Capital Management LLC lifted its position in Phibro Animal Health by 2.4% during the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock worth $394,000 after purchasing an additional 448 shares during the period. Rhumbline Advisers increased its stake in shares of Phibro Animal Health by 0.6% in the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock valued at $1,608,000 after buying an additional 484 shares during the period. Los Angeles Capital Management LLC increased its stake in shares of Phibro Animal Health by 2.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock valued at $505,000 after buying an additional 503 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Phibro Animal Health by 4.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company’s stock valued at $260,000 after buying an additional 546 shares during the period. Finally, New York State Teachers Retirement System increased its stake in shares of Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after buying an additional 775 shares during the period. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.